The largest database of trusted experimental protocols

163 protocols using trypsin

1

Culturing Melanoma Cell Lines WM115 and G361

Check if the same lab product or an alternative is used in the 5 most similar protocols
WM115 cells originating from a primary melanoma (received as a generous gift from Piia Takabe, MSc, and Docent Sanna Pasonen-Seppänen, PhD, Institute of Biomedicine, University of Eastern Finland) were cultured in High Glucose DMEM (PAA Cell Culture Company, Cambridge, UK) supplemented with 5 % inactivated fetal bovine serum (FBS) (PAA Cell Culture Company), 2 mM glutamine (Lonza, Basel, Switzerland), 1 mM sodium pyruvate (Thermo Fisher Scientific, Waltham, MA, USA) and 50 U/mL penicillin – 50 µg/mL streptomycin sulfate (Lonza). Cells were passaged twice a week at a 1:10 split ratio using 0.02% trypsin (w/v) - 0.02% EDTA (w/v) (Lonza).
G361 cells originating from a primary melanoma (Sigma-Aldrich, Munich, Germany) were cultured in McCoy’s 5a medium (Sigma-Aldrich, order No. 88030401) supplemented with 2 mM glutamine (Lonza) and 10% FBS (PAA Cell Culture Company). Cells were passaged twice a week at a 1:10 split ratio using 0.02% trypsin (w/v) - 0.02% EDTA (w/v) (Lonza).
+ Open protocol
+ Expand
2

Expansion of Human Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
hMSCs were purchased from Lonza (Basel, Switzerland) and cultured in MF-medium (TOYOBO, Tokyo, Japan). For the maintenance of hMSCs, the culture media were replenished every 2 days. hMSCs were detached and dissociated into single cell suspension by 4–5 min incubation with Trypsin solution [Trypsin/ethylenediaminetetraacetic acid (EDTA) for Mesenchymal Stem Cells, Lonza]. Live cell numbers were manually counted using hemocytometer.
+ Open protocol
+ Expand
3

Culturing Mucoepidermoid Carcinoma Spheroids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-adherent spheroids derived from mucoepidermoid carcinoma cells (salispheres) were cultured in ultralow attachment 6-well plates (Corning; Corning, NY, USA) for 10 days with DMEM-F12 (Invitrogen, Carlsbad, CA, USA) supplemented with 1% N-2 supplement (Invitrogen), 1% GlutaMAX (Invitrogen), 1% penicillin/streptomycin (Invitrogen), 1 μM dexamethasone (MilliporeSigma), 10 μg/ml insulin (MilliporeSigma), 20 ng/ml EGF (MilliporeSigma), and 20 ng/ml basic fibroblast growth factor (bFGF; MilliporeSigma). For in vitro passaging, salispheres were exposed to 0.25% trypsin (MilliporeSigma) for 5 min, and then mechanically dissociated. A neutralizing solution (TNS; Lonza) was used to neutralize trypsin. Cells were counted and then added to new 6-well ultralow attachment plates (Corning; Corning, NY, USA). Colonies of 50 cells or more were considered salispheres.
+ Open protocol
+ Expand
4

Passaging A549 Cells with Trypsin

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 cells were passaged when they were 80% confluent, about every third day. Media was removed by aspiration and 5 ml of phosphate buffered saline pH 7.2 (Lonza Verviers SPRL, Belgium) were added to wash adherent cells. To detach the adherent cells, 1 ml of 2.5% (w/v) Trypsin (Lonza Verviers SPRL, Belgium) was added to the T-25 flasks and cells were incubated for 5 min at 37 °C. Then, cells were detached and observed under the inverted microscope (Micro master inverted digital microscope, Thermo Fisher Scientific Inc., USA) every 2–3 min.
+ Open protocol
+ Expand
5

Cell Culture of Common Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA)
and resulted negative for mycoplasma test (MycoAlert TM Mycoplasma Detection Kit, Lonza Sales AG, Verviers, Belgium). Murine fibroblasts (NIH/3T3), melanoma (B16.F10) and human umbilical vein endothelial (HUVEC) cells were cultured as monolayers at 37°C in a 5% CO 2 -containing humidified atmosphere in Dulbecco's modified Eagle's medium (DMEM). The medium was supplemented with 10% (v/v) of heat-inactivated foetal bovine serum, 2 mM of Glutamine, 100 U/ml of penicillin and 100 μg/ml of streptomycin. At 80% confluency, cells were trypsinized with 0.01% trypsin and 0.02% EDTA in Phosphate-buffered Saline (PBS). All cells employed for cellular tests were at passages included between 5 and 10. Culture medium, fetal bovine serum, penicillin-streptomycin mixture and trypsin were all purchased from Lonza (Lonza Sales AG, Verviers, Belgium).
+ Open protocol
+ Expand
6

Culturing Mouse Melanoma B16-F10 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B16‐F10 (mouse melanoma cells) were obtained from American Type Culture Collection. B16‐F10 cells were cultured in EMEM supplemented with 10% FBS, 100 μg/mL penicillin and 100 μg/mL streptomycin. The cells were grown at 37°C in a humidified atmosphere containing 5% CO2. At confluence, cells were detached by adding 1 mL of Trypsin–EDTA solution (0.25%w/v Trypsin, 0.53 mM EDTA). EMEM, FBS and Trypsin were purchased from Lonza (Verviers, Belgium). The penicillin–streptomycin mixture was purchased from Sigma Chemical Co. (St. Louis, MO, USA).
+ Open protocol
+ Expand
7

HepG2 Cell Culture and Hydrogel Embedding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two
vials containing approximately 2 million HepG2 cells at passage 99
were kindly provided by “Istituto Zooprofilattico Sperimentale
della Lombardia e dell’ Emilia-Romagna”. Cells were
thawed, counted in a hemocytometer by means of the trypan blue (Sigma-Aldrich,
Lot. no. RNBD9396, US) exclusion assay, and seeded in a 6-well plate
with a seeding ratio of approximately 300,000 cells/well. The medium
used to culture cells was composed of EMEM with Earl’s salts
(EuroClone, Cat. no. ECB2071L, IT), 10% (v/v) FBS (EuroClone, Lot.
no. EU-S021179, IT), 1% (v/v) Na pyruvate (EuroClone, Lot. no. EU-M00QU,
IT), 1% (v/v) glutamine (EuroClone, Lot. no. EU-M0150017, IT) and
1% (v/v) penicillin–streptomycin (Lonza, Lot. no. 2MB027, BE),
and was refreshed every 48 h. Cells were expanded up to passage 6
and then cryopreserved (106 cells/cryovial) in complete
medium + 10% (v/v) DMSO (Sigma-Aldrich, Lot. no. SZBD2870V, US). To
be embedded within hydrogels, cells were expanded, detached with trypsin
(Lonza, Lot. no. 4MB146, BE), counted, suspended in a fresh medium,
and embedded within gels as described in 2.3 at a final density of
3 × 106 cells/gel. Hydrogels were then submerged with
2 mL of fresh medium and incubated at 37 °C, 95% humidity, and
5% CO2.
+ Open protocol
+ Expand
8

Cell Culture of Jurkat and HEK293G Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Jurkat cells (clone E6-1) were maintained in T175 flasks containing RPMI 1640 medium (Lonza) supplemented with 10% fetal calf serum (FCS; Sigma Aldrich) and 2 mM L-glutamine (Sigma Aldrich) at 37°C/5% CO2. Fresh medium was added to the cells every 2-3 days. Cells were passaged at 70% confluency by withdrawing 2.5 ml of the cells into a fresh T175 flask with medium. HEK293G cells (Glosensor cAMP HEK293, Promega) were grown in T75 flasks containing 25 ml Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma Aldrich, UK) supplemented with 10% FCS at 37°C/5% CO2. Cells were passaged at 70-80% confluency using phosphate buffered saline (PBS; Lonza) and trypsin (0.25% w/v in versene; Lonza). A mixed population HEK293G cell line was created by transfecting cells with the LgBiT-CXCR4 construct using FuGENE® (Promega) according to the manufacturer’s instructions, followed by selective pressure (1 mg/ml G418) for two to three weeks. HEK293G cells stably expressing the SNAP-CXCR4 construct were kindly gifted from Dr. J. Goulding (University of Nottingham).
+ Open protocol
+ Expand
9

STRO-1+ Stem Cell Culture and Osteogenic Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
STRO-1+–enriched SSCs were maintained at 5% CO2 at 37°C in culture
flasks and used at passage 1. Cell culture media used was basal culture media
unless otherwise stated. Osteogenic media was basal media supplemented with
10 nM vitamin D3 (Sigma) and 100 μM ascorbic acid (Sigma). Prior to
seeding, cells were treated with collagenase IV (Sigma) and released from the
flask using 1× trypsin (Lonza). STRO-1+ SSC were seeded into 24-well plates at
1000 cells/cm2. After 24 h of seeding, surfaces were transferred
to new 24-well plate and media replaced. Media was subsequently changed every
3–4 days for the duration of the experiments.
+ Open protocol
+ Expand
10

Quantifying 3D Cancer Cell Morphogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Morphogenesis assays were performed by mixing cells with ECM (BD Biosciences Matrigel catalog #356231 or Trevigen Cultrex catalog #3443-005-01) on ice, plated in triplicate into 24-well tissue culture plates, and incubated at 37 °C and 5% CO2. After solidification for 30 min, culture media was added. For coculture experiments, CAFs were either overlaid on top of solidified Cultrex matrix or coembedded with TUM622 at the time of plating at a ratio of 2:1. Cultures were kept for 8 d to 12 d, with media replaced every 2 d. Serial passaging of TUM622 acini was performed by extracting acini (day 10) from the ECM via Cultrex 3D-cell harvesting kit (catalog #3448-020-K; Trevigen) according to manufacturer’s recommendation. Acini were made into a single-cell suspension with trypsin (catalog #CC-5034; Lonza) and replated as described above. Inhibition of Notch and Wnt signaling pathway in 3D cultures was performed with small-molecule inhibitors/agonist IWR-1 (catalog #681669; EMD Millipore), CHIR-99021 (catalog #SML1046; Sigma) and DBZ (catalog #4489; Tocris) at the indicated concentrations. Media containing inhibitors/agonists were replaced once every 2 d for 10 d. The number and size of acini/spheroids were quantified with GelCount (Oxford Optronix, Inc.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!